/

TMCI

Treace Medical Concepts, Inc.After hours

4.100.00 0.00%USD

NasdaqGS · as of Oct 13, 16:00 ET · 15m delay

Open

4.09

Prev close

4.10

Day range

4.054.16

52-week range

1.177.08

Volume

112.19K0.36×

Mkt cap

266.64M

P/E ttm

—

Fwd P/E

-4.82

EPS ttm

-0.9200

Div yield

0.00%

Earnings

Aug 7, 2026

From 52w high

−42.09%

Price Chart

Yahoo Finance · delayed

TMCIOct 13, 2026O 4.09H 4.16L 4.05C 4.100.00 (0.00%)Vol 112.19K

SMA 504.51
SMA 2003.13

1Y change −30.27% since Oct 10, 2025 close540 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

TMCI Treace Medical Concepts, Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: +2.50%
1 month: −9.09%
3 months: −7.66%
6 months: +92.49%
Year to date: +67.35%
1 year: −31.67%

Valuation & ownership

Market cap: 266.64M
Enterprise value: 294.07M
P/E (ttm): —
Forward P/E: -4.82
PEG ratio: —
Price / book: 3.93
Price / sales (ttm): 1.30
EV / EBITDA: -6.34
EPS (ttm): -0.9200
EPS (forward): -0.8500
Beta (5y monthly): 1.49
Dividend yield: 0.00%
Payout ratio: —
Shares outstanding: 65.03M
Float: 47.80M
Short % of float: 3.81%
Short ratio (days): 8.87
Held by insiders: 25.24%
Held by institutions: 49.67%
Avg volume (3m): 313.10K
50-day average: 4.52
200-day average: 3.12
52-week change: −31.67%
S&P 500 52-week: +17.50%

Technicals (daily)

RSI (14): 41.9
vs 50-day SMA: −9.03%
vs 200-day SMA: +31.00%
50 / 200-day trend: ▲ 50 above 200
MACD vs signal: ▼ below
ATR (14) % of price: 5.72%
Realised vol (20d, ann.): 51.1%
From 52-week high: −42.09%
From 52-week low: +250.43%

ANR

Analyst Consensus

3 analysts

Consensus

—

Mean target

5.50

+34.15% implied

Low 4.50Median 5.00High 7.00

Recommendation trend

Now1 / 3 / 1
1m ago1 / 3 / 1

DES

About Treace Medical Concepts, Inc.

Yahoo Finance profile

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Sector: Healthcare
Industry: Medical Devices
Employees: 450

SEAS

Seasonality · TMCI

2021–2026 · monthly returns

Strongest month Jan +9.64%Weakest month May −13.00%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-5.3	-19.8	-28.0	35.1	91.2	15.0	8.3	9.0	-5.5	-7.7			+67.3%
2025	35.1	-11.0	-6.2	-15.6	-18.9	2.4	-8.7	36.7	-8.6	-4.8	-53.4	-17.8	−67.1%
2024	5.7	-0.3	-2.9	-20.5	-43.3	13.1	8.7	-14.7	-6.0	-19.7	82.8	-12.7	−41.6%
2023	0.4	-7.1	17.4	-2.8	8.6	-3.8	-10.9	-31.8	-15.7	-23.5	-12.7	45.5	−44.5%
2022	-2.7	18.7	-12.2	3.6	-14.8	-14.1	18.0	18.4	10.2	10.9	-5.4	-0.7	+23.3%
2021					3.5	-3.7	-3.2	-16.6	6.5	-14.3	-24.9	7.7	−40.6%

INSD

Insider Activity · TMCI

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Aug 23, 2026	Treace John T.Chief Executive Officer	Purchase at price 4.34 - 4.44 per share.	55.9K	$246.65K
Jun 10, 2026	Treace John T.Chief Executive Officer	Purchase at price 4.02 - 4.04 per share.	52.3K	$210.97K
Jun 10, 2026	Treace John T.Chief Executive Officer	Purchase at price 4.02 - 4.04 per share.	24.6K	$99.20K
May 31, 2026	Treace John T.Chief Executive Officer	Purchase at price 3.56 per share.	50K	$177.91K
May 27, 2026	Treace John T.Chief Executive Officer	Purchase at price 2.79 - 3.02 per share.	115.5K	$340.59K
May 18, 2026	Hanna BetsyDirector	Stock Award(Grant) at price 0.00 per share.	30K	—
May 18, 2026	Kiernan Jane E.Director	Stock Award(Grant) at price 0.00 per share.	30K	—
May 18, 2026	Hamilton Lawrence WDirector	Stock Award(Grant) at price 0.00 per share.	30K	—
May 18, 2026	Bakewell John KDirector	Stock Award(Grant) at price 0.00 per share.	30K	—
May 18, 2026	Berry Lance ADirector	Stock Award(Grant) at price 0.00 per share.	30K	—
May 18, 2026	Jain DeeptiDirector	Stock Award(Grant) at price 0.00 per share.	30K	—
May 13, 2026	Treace John T.Chief Executive Officer	Purchase at price 2.17 - 2.62 per share.	153.8K	$375.50K
Mar 31, 2026	Hair MarkChief Financial Officer	Stock Award(Grant) at price 0.00 per share.	100K	—
Feb 9, 2026	Scanlan Sean FOfficer	Conversion of Exercise of derivative security at price 1.05 per share.	16.9K	$17.72K
Jan 21, 2026	Scanlan Sean FChief Technology Officer	Stock Award(Grant) at price 0.00 per share.	262.5K	—
Jan 21, 2026	Treace John T.Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	250K	—
Jan 21, 2026	Elder Scot MichaelOfficer	Stock Award(Grant) at price 0.00 per share.	262.5K	—
Jan 21, 2026	Guglielmino GaetanoOfficer	Stock Award(Grant) at price 0.00 per share.	150K	—
Jan 21, 2026	Hair MarkChief Financial Officer	Stock Award(Grant) at price 0.00 per share.	375K	—
Jan 20, 2026	Scanlan Sean FChief Technology Officer	Conversion of Exercise of derivative security at price 0.72 per share.	53.5K	$38.52K

13F

Investors Holding TMCI

latest 13F filings of 29 followed managers

Investors holding TMCI
Investor	Value	Of portfolio	Shares	Change	Quarter
Renaissance Technologies	$192.2K	0.00%	48.30K	−91%	Q2 2026

From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors

TMCI

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

TMCI

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Treace Medical Concepts, Inc.

Seasonality · TMCI

Insider Activity · TMCI

Congress Trades · TMCI

Investors Holding TMCI

Investors Holding TMCI

Congress Trades · TMCI

Insider Activity · TMCI

Seasonality · TMCI

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Treace Medical Concepts, Inc.

Financial Snapshot

Earnings & Dividends

News